CCA
CRXTW

Cruiser Capital Advisors’s Clarus Therapeutics Holdings, Inc. Warrants CRXTW Stock Holding History

Cruiser Capital Advisors’s Portfolio CRXTW Stock Details CRXTW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,700
Closed -$11K – 61
2021
Q1 		$11K Buy
+19,700
New +$15.8K 0.01% 48

Other funds holding CRXTW

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
BFM
Boothbay Fund Management New York $4.34B AUM 106.31% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $4.21B AUM 35.27% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
RCM
Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.39B AUM 64.83% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $574M AUM 6.51% 1-Year Est. Return